Dynamic prognostication and treatment planning for hepatocellular carcinoma: A machine learning-enhanced survival study using multi-centric data

<p>A reliable system for dynamic prognostication and management of hepatocellular carcinoma (HCC) is urgently needed but currently unavailable. In our previous work, we developed a machine learning algorithm termed "Survival Path" (raw-SP) to enhance prognostication with longitudinal survival data. However, the previous model was limited to intermediate stage HCC patients, and it faced the risk of overfitting due to path proliferation. In this study, we developed a novel framework incorporating nodal fusion techniques to mitigate the risk of overfitting, and expanded the model's applicability to all stages of HCC patients. A post-fusion survival map (fusion-SP) containing 14 different paths was built, which demonstrated superior or non-inferior accuracy in dynamic prognosis prediction for HCC patients compared with raw-SP, as well as traditional staging systems within the first 15 months since initial diagnosis in large-scale derivation, internal and external validation cohorts. Subgroup analysis showed the fusion-SP demonstrated superior performance in dynamic prognostication compared to other models among patients with BCLC stage C disease and initial tumor burden above up-to-seven criteria. Under the framework of fusion-SP, novel and distinct optimal combination treatment strategies for advanced-stage HCC patients at different key nodes were uncovered, where traditional staging frameworks fall short. The fusion-SP framework could serve as a robust tool for facilitating dynamic prognosis prediction and treatment planning for HCC. Moreover, our streamlined methodology holds the potential to be applied across various types of cancers.</p>

Authors

Publication Details

Journal
The Innovation Medicine
Published
2025-01-01
DOI
https://doi.org/10.59717/j.xinn-med.2025.100125
Citations
12
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
16.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dynamic prognostication and treatment planning for hepatocellular carcinoma: A machine learning-enhanced survival study using multi-centric data

Lujun Shen, Jingjun Huang, Letao Lin, Linbin Lu et al.
12 citations
The Innovation Medicine
Liver Disease Diagnosis and Treatment
16.25
article

Dynamic prognostication and treatment planning for hepatocellular carcinoma: A machine learning-enhanced survival study using multi-centric data

Lujun Shen, Jingjun Huang, Letao Lin, Linbin Lu, Chao An, Feng Shi, Ge Ren, Mengxuan Cui, Weijun Fan, Peihong Wu, Ruizhi Tang, Nan Wu, Yao Wang, Linfeng Li, Chen Li, Kai Li, Chaofeng Li, Zhongguo Zhou, Xiong Chen, Jiming Xu, Zhimei Huang, Yiquan Jiang, Jinhua Huang, Juan Nie, Boyang Chang, Qi Zeng
article en
12 citations

Abstract

<p>A reliable system for dynamic prognostication and management of hepatocellular carcinoma (HCC) is urgently needed but currently unavailable. In our previous work, we developed a machine learning algorithm termed "Survival Path" (raw-SP) to enhance prognostication with longitudinal survival data. However, the previous model was limited to intermediate stage HCC patients, and it faced the risk of overfitting due to path proliferation. In this study, we developed a novel framework incorporating nodal fusion techniques to mitigate the risk of overfitting, and expanded the model's applicability to all stages of HCC patients. A post-fusion survival map (fusion-SP) containing 14 different paths was built, which demonstrated superior or non-inferior accuracy in dynamic prognosis prediction for HCC patients compared with raw-SP, as well as traditional staging systems within the first 15 months since initial diagnosis in large-scale derivation, internal and external validation cohorts. Subgroup analysis showed the fusion-SP demonstrated superior performance in dynamic prognostication compared to other models among patients with BCLC stage C disease and initial tumor burden above up-to-seven criteria. Under the framework of fusion-SP, novel and distinct optimal combination treatment strategies for advanced-stage HCC patients at different key nodes were uncovered, where traditional staging frameworks fall short. The fusion-SP framework could serve as a robust tool for facilitating dynamic prognosis prediction and treatment planning for HCC. Moreover, our streamlined methodology holds the potential to be applied across various types of cancers.</p>

The Innovation MedicineVol. 3(2)
Openalex Percentile: Top 1%
Liver Disease Diagnosis and Treatment
16.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.